# Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

> **NCT00005947** · PHASE3 · COMPLETED · sponsor: **Dendreon** · enrollment: 127 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** sipuleucel-T
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00005947
- **Lead sponsor:** Dendreon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2010-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005947, "Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00005947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*